can i lose weight microdosing tirzepatide Compounded Microdoses - Loss Microdosing GLP-1s | Dr. Jennifer

doi:10.3390/nu12040985 4 Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M

Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks Patients on semaglutide lost an average of 13.7% of their body weight over the same period 47% more tirzepatide patients achieved 25% or greater body weight loss compared to semaglutide Tirzepatide also produced greater reductions in waist circumference across all dose comparisons A 2024 meta-analysis published in JAMA Internal Medicine analyzing real-world data from over 140,000 patients confirmed the same pattern: tirzepatide produced an average of 4.23 kg more weight loss than semaglutide across all doses and durations studied

GLP-1 medications are longer-acting versions of this signal, which is why they reduce appetite and support sustained weight loss

Chronic kidney diseases and inflammation research: a bibliometric analysis

As weight drops, hormones are released into circulation, potentially disrupting cycles